Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139,485 | 158,137 | 173,192 | 124,429 | 144,389 |
| Other current assets | 0 | 0 | 2,000 | 2,000 | 2,000 |
| TOTAL | $142,130 | $161,555 | $178,470 | $130,597 | $149,868 |
| Non-Current Assets | |||||
| PPE Net | 7,485 | 7,613 | 10,513 | 10,686 | 10,826 |
| Other Non-Current Assets | 10,749 | 11,049 | 11,410 | 11,716 | 12,037 |
| TOTAL | $18,234 | $18,662 | $21,923 | $22,402 | $22,863 |
| Total Assets | $160,364 | $180,217 | $200,393 | $152,999 | $172,731 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,592 | 4,932 | 8,718 | 10,380 | 6,366 |
| Accrued Expenses | 12,862 | 12,608 | 11,875 | 13,562 | 12,284 |
| TOTAL | $26,227 | $29,335 | $34,176 | $38,637 | $36,756 |
| Non-Current Liabilities | |||||
| Long Term Debt | 43,942 | 42,971 | 37,835 | 40,512 | 40,508 |
| Deferred Revenues | 9,773 | 11,795 | 13,583 | 14,695 | 18,106 |
| Other Non-Current Liabilities | 18,670 | 19,114 | 19,514 | 20,001 | 20,530 |
| TOTAL | $62,612 | $62,085 | $57,349 | $60,513 | $61,038 |
| Total Liabilities | $88,839 | $91,420 | $91,525 | $99,150 | $97,794 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 205,002 | 204,943 | 204,943 | 187,018 | 187,018 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -602,305 | -583,520 | -557,996 | -537,068 | -513,007 |
| Other shareholders' equity | -4,031 | -2,328 | 2,405 | -251 | 0 |
| TOTAL | $71,525 | $88,797 | $108,868 | $53,849 | $74,937 |
| Total Liabilities And Equity | $160,364 | $180,217 | $200,393 | $152,999 | $172,731 |